Magnet Biomedicine logo

Magnet Biomedicine

Recent Finacing

Equity

Recent Raise

$50M


Magnet Biomedicine is a biotechnology company that develops TrueGlues compounds to induce cooperative protein-protein interactions, aiming to optimize therapeutic impact and address undruggable proteins in areas such as cancer, cardiovascular disease, and immune disorders.

Total Funding

$50M

Headquarters

Cambridge, USA

Founded

N/A

Focus Areas

Biotechnology
Drug Discovery
Therapeutic Development

Investors

ARCH Venture Partners logo
Newpath Partners logo